DOI:10.2214/AJR.05.1079
AJR 2006; 187:W375-W385
© American Roentgen Ray Society
Hydro-MRI of the Small Bowel: Effect of Contrast Volume, Timing of Contrast Administration, and Data Acquisition on Bowel Distention
Christiane A. Kuehle1,
Waleed Ajaj1,
Susanne C. Ladd1,
Sandra Massing1,
Joerg Barkhausen1 and
Thomas C. Lauenstein1
1 All authors: Department of Diagnostic and Interventional Radiology and
Neuroradiology, University Hospital Essen, Hufelandstrasse 55, D-45122 Essen,
Germany.
Received June 23, 2005;
accepted after revision August 22, 2005.
Address correspondence to C. A. Kuehle
(christiane.kuehle{at}uni-essen.de).
WEB
This is a Web exclusive article.
Abstract
OBJECTIVE. The purpose of this study was to assess oral contrast
agents, volumes of the agents, and time points of data acquisition in regard
to small-bowel distention and patient acceptance.
SUBJECTS AND METHODS. Six healthy volunteers underwent imaging on 16
different days. Four volumes (450, 900, 1,350, and 1,800 mL) of each of the
four contrast compounds (0.2% locust bean gum plus 2.5% mannitol, VoLumen
containing 2.0% sorbitol, VoLumen containing 1.4% sorbitol, and tap water)
were used. Two-dimensional true fast imaging with steady-state free precession
data sets were acquired at 5-minute intervals after contrast ingestion.
Distention values for small-bowel segments (duodenum, proximal and distal
jejunum, ileum) and occurrence of side effects were documented.
RESULTS. Analysis of bowel distention revealed significantly greater
distention for all carbohydrate sugar alcohol-containing solutions compared
with water but no significant difference among the three contrast agents.
Sufficient duodenal distention was achieved with 900 mL of any of the contrast
agents, but imaging had to be performed soon after ingestion. For MRI of the
distal jejunum and ileum, a volume of 1,350 mL is preferable, and the time
point of data acquisition plays a minor role. Ingestion of 1,800 mL of the
carbohydrate sugar alcohol solutions led to a significantly higher rate of
side effects such as abdominal cramps than did ingestion of smaller
volumes.
CONCLUSION. The data indicate that sufficient contrast consumption
and optimal timing of data acquisition are essential to distention of the
small bowel. Oral contrast agent protocols should be adapted to the bowel
region in question.
Keywords: abdominal imaging bowel distention data acquisition MRI oral contrast agents small bowel
Introduction
Routine cross-sectional imaging procedures require delineation of the small
bowel. Assessment of the pancreatic parenchyma by CT or MRI can be improved by
duodenal distention [1,
2]. To that end, oral ingestion
of water before the examination has been proposed
[1-3].
Furthermore, evaluation of the small bowel itself requires complete distention
and delineation of small-bowel loops, which are often collapsed and
nondistended in their physiologic state. Various strategies have been used to
ensure sufficient small-bowel filling. Administration of contrast agents
through a duodenal tube usually leads to homogeneous small-bowel distention
[4,
5]. However, this approach
makes the procedure invasive, and the fluoroscopic guidance exposes the
patient to ionizing radiation.
To avoid the drawbacks, oral administration of liquid contrast medium seems
to be an attractive alternative to insertion of a tube. Water, which is ideal
in terms of cost and patient tolerance, has been proposed for small-bowel MRI
[6,
7]. Use of water, however, has
a poor distention rate because water is quickly resorbed in the
gastrointestinal tract. Various additives have been shown to decrease water
resorption and have been proposed as oral contrast agents for cross-sectional
imaging
[8-11].
To our knowledge, there is no general agreement regarding required volumes of
contrast agents, timing of administration of the agents, or timing of data
acquisition to visualize small-bowel loops. Our aim was to assess oral
contrast agents, volumes of contrast agents, and time points of data
acquisition in regard to small-bowel distention and patient acceptance.
Subjects and Methods
Subjects
Six healthy volunteers (four women, two men; median age, 36 years; age
range, 28-47 years; median body mass index, 23.3; body mass index range,
18-28) were included in this study. Any history of gastrointestinal disease or
gastrointestinal symptoms (postprandial belching, nausea, early satiety) was
excluded with use of a standardized questionnaire. The study protocol was
approved in accordance with the local institutional review board. Written
informed consent was obtained from all subjects before they were examined.
Each volunteer underwent 16 MRI examinations on separate days. The interval
between examinations was at least 24 hours.
Oral Contrast Agents
Four oral contrast agents were tested. In a baseline examination, tap water
was used (agent A). The other compounds were a homemade hydrosolution (agent
B) containing 0.2% locust bean gum and 2.5% mannitol and two commercially
available solutions: VoLumen containing 1.4% sorbitol (E-Z-EM) (agent C) and
VoLumen containing 2.0% sorbitol (E-Z-EM) (agent D). To assure homogeneity of
bowel activity for all subjects and examinations, MRI was performed after a
4-hour fasting period. Before each examination, the volunteers were asked to
ingest 450 mL, 900 mL, 1,350 mL, or 1,800 mL of contrast agent. Ingestion was
done at a steady, evenly distributed rate of approximately 40 mL/min.
Ingestion time was measured with a stopwatch. After ingestion of the first 100
mL of each solution, 100 mg erythromycin was administered IV to enhance
gastric emptying [12,
13]. The examinations were
performed in a randomized order regarding type and volume of oral contrast
compound.
MRI Examination Protocol
MRI examinations were performed on a 1.5-T MRI system (Magnetom Sonata,
Siemens Medical Solutions) equipped with a high-performance gradient system
characterized by a maximum gradient amplitude of 40 mT/m and a slew rate of
200 mT/m/ms. For signal reception a set of two large flex surface coils were
used to obtain coverage of the entire abdomen and pelvis. Neither a
spasmolytic agent nor paramagnetic contrast compound was used. Coronal 2D
images were collected with the subject in the prone position and performing a
breath-hold. True fast imaging with steady-state free precession sequence
parameters were as follows: TR/TE, 4.3/2.15; flip angle, 70°; field of
view, 50 cm; slice thickness, 3 mm; intersection gap, 0.3 mm; matrix size, 201
x 256; acquisition time, 20 seconds. Data acquisition was performed
seven times: immediately after contrast ingestion (time = 0) and 5, 10, 15,
20, 30, and 45 minutes after ingestion. During this time period, patients
stayed in the imager.
Data Analysis
The data sets were evaluated on a postprocessing workstation (Virtuoso,
Siemens Medical Solutions). In a first step the small bowel was divided into
four segments: duodenum, proximal jejunum, distal jejunum, and ileum. Images
were analyzed in a consensus mode by two radiologists blinded to dose and type
of oral contrast agent and to data acquisition time. They quantified bowel
distention for each segment using a visual 5-grade ranking (5 = very good
distention, 1 = collapsed bowel).
Twenty-four hours after each MRI examination, the subjects were questioned
about the occurrence of side effects such as diarrhea, flatulence, vomiting,
regurgitation, and abdominal spasms. For this purpose, a standardized
questionnaire with a 4-point scale (1 = no side effects, 4 = severe side
effects) was used. In addition, subject acceptance concerning volume, taste,
consistency, and smell of each of the four contrast agents was documented with
a 4-point scale (1 = no objections, 4 = severe objections). Results for each
contrast agent in regard to distention, side effects, and acceptance were
compared by use of a Wilcoxon rank test.
Results
Subjects ingested 450 mL, 900 mL, and 1,350 mL of each contrast compound at
the predetermined rate of 40 mL/min. The target time of ingesting 1,800 mL
within 45 minutes was achieved by all volunteers for contrast agents A (water)
and B (locust bean gum/mannitol). However, consumption of 1,800 mL of
hydrosolution agents C and D was prolonged as much as 65 minutes because of
higher viscosity and intense taste. Mean bowel distention results for all six
volunteers are displayed in Tables
1 and
2.
Distention of Small-Bowel Segments
Average distention values for single bowel segments are shown in
Figure 1. Loops of proximal
jejunum had the least distention with a mean value of 1.8. The most distention
occurred in the ileum (maximum rating, 4.1).

View larger version (14K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1 Graph shows differences in average distention values at all
time points of data acquisition for small-bowel segments. Least distention
occurred in proximal jejunum (mean grade, 1.8). Most distention occurred in
ileum (maximum rating, 4.1). LBG = locust bean gum with mannitol. VoLumen,
E-Z-EM.
|
|
Influence of Type of Contrast Medium
Mean bowel distention values for all acquisition time points and volumes
are shown in Figure 2A. For the
duodenum and proximal jejunum, there were no statistically significant
differences among the four substances (Figs.
2B,
2C,
2D, and
2E). Water, however, proved
inferior to all other agents in distention of the distal jejunum (1,350 mL of
contrast agent: A over B, p = 0.028; A over C, p = 0.028; A
over D, p = 0.028) and ileum (Figs.
2F,
2G,
2H, and
2I) (1,350 mL of contrast
agent: A over B, p = 0.028; A over C, p = 0.028; A over D,
p = 0.028). There was no statistical difference among agents B, C,
and D for those small-bowel segments.

View larger version (14K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A Influence of type of contrast medium. Graph shows mean grade
of bowel distention after ingestion of one of four contrast media without
regard to acquisition time points or volume. For duodenum, there were no
statistically significant differences between substances. Water, however,
proved inferior to other agents for distention of proximal and distal jejunum
and ileum. There was no statistical difference among agents B, C, and D for
those bowel segments. LBG = locust bean gum with mannitol.
|
|

View larger version (156K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B Influence of type of contrast medium. 29-year-old woman in
good health. MR images show influence of type of contrast medium on duodenum.
For duodenum there were no statistically significant differences between
substances. All agents administered at volume of 900 mL. Water.
|
|

View larger version (149K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2C Influence of type of contrast medium. 29-year-old woman in
good health. MR images show influence of type of contrast medium on duodenum.
For duodenum there were no statistically significant differences between
substances. All agents administered at volume of 900 mL. Locust bean gum with
mannitol.
|
|

View larger version (151K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2D Influence of type of contrast medium. 29-year-old woman in
good health. MR images show influence of type of contrast medium on duodenum.
For duodenum there were no statistically significant differences between
substances. All agents administered at volume of 900 mL. VoLumen (E-Z-EM) with
1.4% sorbitol.
|
|

View larger version (140K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2E Influence of type of contrast medium. 29-year-old woman in
good health. MR images show influence of type of contrast medium on duodenum.
For duodenum there were no statistically significant differences between
substances. All agents administered at volume of 900 mL. VoLumen with 2%
sorbitol.
|
|

View larger version (102K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2F Influence of type of contrast medium. 28-year-old man in good
health. MR images show influence of type of contrast medium on ileum
(arrow). There was no statistical difference among agents in regard
to ileal distention. All agents administered at volume of 1,350 mL. Water.
|
|

View larger version (98K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2G Influence of type of contrast medium. 28-year-old man in good
health. MR images show influence of type of contrast medium on ileum
(arrow). There was no statistical difference among agents in regard
to ileal distention. All agents administered at volume of 1,350 mL. Locust
bean gum with mannitol.
|
|

View larger version (103K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2H Influence of type of contrast medium. 28-year-old man in good
health. MR images show influence of type of contrast medium on ileum
(arrow). There was no statistical difference among agents in regard
to ileal distention. All agents administered at volume of 1,350 mL. VoLumen
with 1.4% sorbitol.
|
|

View larger version (111K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2I Influence of type of contrast medium. 28-year-old man in good
health. MR images show influence of type of contrast medium on ileum
(arrow). There was no statistical difference among agents in regard
to ileal distention. All agents administered at volume of 1,350 mL. VoLumen
with 2% sorbitol.
|
|
Timing of Data Acquisition
Average distention ratings depending on the time point of image acquisition
are displayed in Figure 3A.
Data analysis for the duodenum and proximal jejunum showed that prompt data
acquisition after ingestion was essential (Figs.
3B,
3C,
3D,
3E, and
3F). Fifteen minutes after
ingestion, distention decreased significantly in these two bowel segments
(duodenum: time = 0 over time = 15 minutes, p = 0.028; proximal
jejunum: time = 0 over time = 15 minutes, p = 0.028). For the distal
jejunum and ileum, however, distention did not show statistically significant
differences for imaging 20-45 minutes after contrast ingestion (Figs.
3G,
3H,
3I,
3J, and
3K).

View larger version (16K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3B Timing of data acquisition. Graph of results of data analysis
for duodenum shows prompt data acquisition after ingestion was essential.
Fifteen minutes after ingestion, distention decreased significantly in
duodenum and proximal jejunum.
|
|

View larger version (111K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3C Timing of data acquisition. 29-year-old woman in good health.
MR images of duodenum (arrow) obtained with 1,350 mL locust bean gum
with mannitol. Data analysis showed prompt data acquisition after ingestion
was essential in duodenum and proximal jejunum. Time zero.
|
|

View larger version (112K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3D Timing of data acquisition. 29-year-old woman in good health.
MR images of duodenum (arrow) obtained with 1,350 mL locust bean gum
with mannitol. Data analysis showed prompt data acquisition after ingestion
was essential in duodenum and proximal jejunum. Fifteen minutes after contrast
ingestion, distention is significantly decreased.
|
|

View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3E Timing of data acquisition. 29-year-old woman in good health.
MR images of duodenum (arrow) obtained with 1,350 mL locust bean gum
with mannitol. Data analysis showed prompt data acquisition after ingestion
was essential in duodenum and proximal jejunum. Thirty minutes after contrast
ingestion.
|
|

View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3F Timing of data acquisition. 29-year-old woman in good health.
MR images of duodenum (arrow) obtained with 1,350 mL locust bean gum
with mannitol. Data analysis showed prompt data acquisition after ingestion
was essential in duodenum and proximal jejunum. Forty-five minutes after
contrast ingestion.
|
|

View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3H Timing of data acquisition. 29-year-old woman in good health.
MR images obtained with 1,350 mL VoLumen (E-Z-EM) with 1.4% sorbitol show
ileum. Ileal distention had no statistically significant differences for
imaging between time zero and 45 minutes after contrast ingestion. Time
zero.
|
|

View larger version (103K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3I Timing of data acquisition. 29-year-old woman in good health.
MR images obtained with 1,350 mL VoLumen (E-Z-EM) with 1.4% sorbitol show
ileum. Ileal distention had no statistically significant differences for
imaging between time zero and 45 minutes after contrast ingestion. Fifteen
minutes after contrast ingestion.
|
|

View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3J Timing of data acquisition. 29-year-old woman in good health.
MR images obtained with 1,350 mL VoLumen (E-Z-EM) with 1.4% sorbitol show
ileum. Ileal distention had no statistically significant differences for
imaging between time zero and 45 minutes after contrast ingestion. Thirty
minutes after contrast ingestion.
|
|

View larger version (101K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3K Timing of data acquisition. 29-year-old woman in good health.
MR images obtained with 1,350 mL VoLumen (E-Z-EM) with 1.4% sorbitol show
ileum. Ileal distention had no statistically significant differences for
imaging between time zero and 45 minutes after contrast ingestion. Forty-five
minutes after contrast ingestion.
|
|
Influence of Contrast Volume
Results for the four contrast volumes are shown in
Figure 4A. A volume of 1,350
mL gave the best mean results for contrast agents B, C, and D, and these
results did not improve with expansion of the volume to 1,800 mL. For the
duodenum (Figs. 4B,
4C,
4D,
4E, and
4F) and the proximal jejunum,
the increase in distention with administration of 900 mL, 1,350 mL, and 1,800
mL of agent was only moderate (duodenum: 900 mL over 1,800 mL, p =
0.674; proximal jejunum: 900 mL over 1,800 mL, p = 0.674). Expanding
the dose from 450 mL to 1,350 mL, however, improved distention of the distal
jejunum and ileum (Figs. 4G,
4H,
4I,
4J, and
4K) in a statistically
significant different way (distal jejunum: 450 mL over 1,350 mL, p =
0.028; ileum: 450 mL over 1,350 mL, p = 0.028).

View larger version (13K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4A Influence of contrast volume. Graph shows results for all
small-bowel segments. Volume of 1,350 mL had best mean results for contrast
agents B, C, and D. Results did not improve with increase in volume to 1,800
mL. LBG = locust bean gum with mannitol.
|
|

View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4H Influence of contrast volume. 29-year-old woman in good
health. MR images obtained 45 minutes after ingestion of VoLumen (E-Z-EM) with
1.4% sorbitol show ileum. Expanding dose of agent from 450 to 1,350 mL led to
statistically significant improvement in distention of ileum
(arrows). 450 mL.
|
|

View larger version (140K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4I Influence of contrast volume. 29-year-old woman in good
health. MR images obtained 45 minutes after ingestion of VoLumen (E-Z-EM) with
1.4% sorbitol show ileum. Expanding dose of agent from 450 to 1,350 mL led to
statistically significant improvement in distention of ileum
(arrows). 900 mL.
|
|

View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4J Influence of contrast volume. 29-year-old woman in good
health. MR images obtained 45 minutes after ingestion of VoLumen (E-Z-EM) with
1.4% sorbitol show ileum. Expanding dose of agent from 450 to 1,350 mL led to
statistically significant improvement in distention of ileum
(arrows). 1,350 mL.
|
|

View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4K Influence of contrast volume. 29-year-old woman in good
health. MR images obtained 45 minutes after ingestion of VoLumen (E-Z-EM) with
1.4% sorbitol show ileum. Expanding dose of agent from 450 to 1,350 mL led to
statistically significant improvement in distention of ileum
(arrows). 1,800 mL.
|
|
Side Effects and Patient Acceptance
There were no side effects after ingestion of tap water at any of the four
doses. The questionnaire results for acceptance of the contrast agents showed
no significant difference regarding volumes of 450-1,350 mL, which were
associated with no or only mild side effects and no or only mild objections
(Fig. 5). Consumption of 1,800
mL of contrast agent, however, led to a significantly higher rate of side
effects compared with lower volumes (450 mL, 900 mL, 1,350 mL over 1,800 mL,
p = 0.024, p = 0.028, p = 0.028, respectively)
because of diarrhea and abdominal cramps (mean score: 2.8 for agent B; 3.7 for
agent C, and 3.8 for agent D).

View larger version (12K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5 Graph shows side effects and subject acceptance at volume of
1,800 mL. Consumption of 1,800 mL of contrast agents B, C, and D led to rate
of side effects significantly higher than that with water (mean score, agent
A, 1; agent B, 2.8; agent C, 3.7; agent D, 3.8). LBG = locust bean gum with
mannitol. VoLumen, E-Z-EM.
|
|
Discussion
MRI of the small bowel in conjunction with oral administration of a
contrast agent is feasible, and there are various methods of optimizing this
imaging technique. Administration of water alone leads to significantly less
bowel distention than the use of an oral contrast agent containing osmotic or
nonosmotic additives, which reduce resorption of water in the gastrointestinal
tract. In addition, there is no linear correlation between the volume of
contrast agent used and the corresponding bowel distention. Rather, a certain
amount of contrast agent gives peak bowel distention, which cannot be
increased with a larger volume of contrast agent. Imaging techniques should be
adapted to the bowel segments in question in terms of contrast dose and timing
of data acquisition.
Luminal distention is key to diagnostic imaging of the small bowel
[14-16]
because collapsed bowel loops can hide even large lesions and give the false
appearance of wall thickening
[4,
17,
18]. For cross-sectional bowel
imaging with CT or MRI, distention can be achieved with a technique analogous
to conventional enteroclysis
[19-22].
After insertion of a duodenal tube, large amounts of a contrast agent such as
methylcellulose can be administered within a relatively short time. This
technique results in excellent bowel distention and high sensitivity and
specificity in the detection of inflammatory lesions
[23]. However, the
practicability of MR and CT enteroclysis is restricted because of patient
discomfort and technical complexity. The nasojejunal tube must be inserted
under fluoroscopic guidance. This procedure requires the use of two diagnostic
rooms and movement of the patient between examinations. In addition, the
procedure is associated with exposure to ionizing radiation. This limitation
is particularly undesirable in examinations of young patients, who often need
several imaging examinations for therapeutic monitoring. Finally, many
patients consider nasojejunal intubation unpleasant and invasive
[24]. Thus strategies have
been evaluated for obviating nasojejunal intubation for MRI of the small
bowel.
The first approaches without intubation were based on oral administration
of tap water alone. Lomas and Graves
[7] performed small bowel MRI
on eight volunteers who had ingested of 1-2 L of water. Rapid acquisition with
relaxation enhancement sequences (half-Fourier single-shot rapid acquisition
with relaxation enhancement) were acquired at 15-minute intervals until the
terminal ileum was visualized. Although the proximal parts of the small bowel
could be assessed in all subjects, the water column reached only the terminal
ileum in six of the eight subjects because of fast intestinal resorption. This
drawback can be considered serious because inflammatory bowel disease is
predominantly found in this part of the small intestine
[25]. These results were
confirmed by our findings: oral water administration led to the worst
distention of all tested contrast solutions, and the greatest discrepancy was
in the ileum.
Contrast compounds should contain additives that bind intraluminal liquid.
Various solutions have been evaluated and are in clinical use. Sood et al.
[26] compared the effects of
polyethylene glycol solutions on bowel distention with the effects of water.
Twenty-two volunteers were examined on 2 days. Ingestion of polyethylene
glycol resulted in significantly better visualization of the distal small
bowel segments. The usefulness of polyethylene glycol as an oral contrast
compound has been confirmed in several clinical studies
[27,
28] involving patients with
Crohn's disease or celiac disease. Other authors have shown the value of
contrast solutions containing osmotic carbohydrate sugar alcohols such as
sorbitol and mannitol [29].
Our results showed that any of the three contrast compounds containing
sorbitol or mannitol had higher distention values than the baseline
examination with water. Although the results were not statistically
significant for all bowel segments, the mannitol solution tended to give the
most distention.
Although the benefit of solutions containing carbohydrate sugar alcohols or
similar substances has been proved in several clinical trials, one study
showed controversial results with water. Wold et al.
[30] assessed two CT
enterography protocols: a noninvasive technique with water administered orally
and CT enteroclysis in conjunction with duodenal intubation. Twenty-three
patients with known or highly suspected Crohn's disease were included. Results
of the CT examinations were compared with those of fluoroscopic examinations
and endoscopic findings. The noninvasive oral water CT protocol turned out to
provide the same level of bowel distention as CT enteroclysis. These results
may appear to be surprising and discordant with those of other studies showing
no practicability of oral water administration. The study by Wold et al. was
conducted with a highly selected patient cohort, mainly of patients with
severe active inflammation. The presence of inflammatory bowel stenosis
resulting in prestenotic bowel dilatation may explain why both CT protocols
had comparable distention ratios. Oral water administration may provide only
moderate distention in patients with slight or no inflammatory bowel disease,
thereby leading to false-negative or false-positive results.
Although CT and MRI techniques for small-bowel imaging are increasingly
used and various oral contrast agents have been propagated, there are no
general guidelines for the required contrast dose or timing of administration
and imaging. Some authors recommend that contrast ingestion take as long as 4
hours [9]. In other protocols,
the solutions are ingested as fast as possible. Patients than stay in the
imager, and imaging is repeated until the terminal ileum is appropriately
visualized [7]. The latter
strategy decreases the practicability of small-bowel imaging, because imagers
may have to be scheduled for larger blocks of time. Our findings can
facilitate imaging protocols for both CT and MRI examinations. The contrast
media and data acquisition times used depend on the bowel segment being
explored. Distention of the duodenum is adequate with only a small amount of
contrast agent (450 mL). However, data acquisition should be performed
immediately after oral contrast administration, because bowel distention
decreases rapidly. For more distal parts of the small bowel, larger contrast
volumes are preferable, but bowel distention is fairly stable at a high level
for 45 minutes. This fact may be explained by the physiologic processes of
small-bowel motility: distention of distal small-bowel segments induces a
decrease in bowel motility by neuronal and hormonal feedback mechanisms
[31]. Once marked distention
is achieved, the effect is twofold: distention is fairly constant, and a
further increase in contrast volume does not improve bowel distention. This
effect may be why the contrast dose of 1,800 mL did not improve image quality.
Lack of patient acceptance and occurrence of side effects may be additional
arguments for not using larger contrast volumes. Except for the water-based
examination, there was a high incidence of side effects such as diarrhea and
abdominal spasms after ingestion of 1,800 mL of the contrast agents.
The present study was not without limitations. Data were acquired for a
population of healthy volunteers. We do not know whether conclusions drawn
from our results are transferable to patients with inflammatory or other bowel
diseases. It is debatable whether a patient with symptoms such as abdominal
pain and nausea would be able to ingest a contrast volume greater than 1,000
mL. However, patients should be motivated to reach the target and ingest more
than 1,000 mL of the agent for sufficient visualization of distal small-bowel
segments. Successful results with the proposed small-bowel imaging strategy
will have to be proved with larger cohorts of patients with inflammatory or
noninflammatory bowel disease. We tested only specific formulas of contrast
agents. Although all of these compounds contained osmotic carbohydrate sugar
alcohols, which are mainly used for CT and MRI of the small bowel, validation
of our findings for every contrast formula cannot be guaranteed. We are
convinced, however, that our proposed protocols may help to establish
guidelines for any kind of oral contrast agent: sufficient duodenal distention
with a small amount of contrast agent and imaging performed soon after
ingestion of the contrast agent. For MRI of more distal parts of the small
bowel, a higher volume (e.g., 1,350 mL) is preferable, but the time point of
data acquisition plays a minor role.
References
- Ramsay DW, Markham DH, Morgan B, Rodgers PM, Liddicoat AJ. The use
of dilute Calogen as a fat density oral contrast medium in upper abdominal
computed tomography, compared with the use of water and positive oral contrast
media. Clin Radiol2001; 56:670
-673[CrossRef][Medline]
- Baldwin GN. Computed tomography of the pancreas: negative contrast
medium. Radiology1978; 128:827
-828[Abstract]
- Winter TC, Ager JD, Nghiem HV, Hill RS, Harrison SD, Freeny PC.
Upper gastrointestinal tract and abdomen: water as an orally administered
contrast agent for helical CT. Radiology1996; 201:365
-370[Abstract/Free Full Text]
- Maglinte DD, Hall R, Miller RE, et al. Detection of surgical
lesions of the small bowel by enteroclysis. Am J Surg1984; 147:225
-229[CrossRef][Medline]
- Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H.
Small-bowel disease: comparison of MR enteroclysis images with conventional
enteroclysis and surgical findings. Radiology2000; 215:717
-725[Abstract/Free Full Text]
- Minowa O, Ozaki Y, Kyogoku S, Shindoh N, Sumi Y, Katayama H. MR
imaging of the small bowel using water as a contrast agent in a preliminary
study with healthy volunteers. AJR1999; 173:581
-582[Free Full Text]
- Lomas DJ, Graves MJ. Small bowel MRI using water as a contrast
medium. Br J Radiol1999; 72:994
-997[Abstract]
- Schunk K, Kern A, Heussel CP, et al. Hydro-MRT with fast sequences
in Crohn's disease: a comparison with fractionated gastrointestinal passage
[in German]. Rofo1999; 170:338
-346[Medline]
- Patak MA, Froehlich JM, von Weymarn C, Ritz MA, Zollikofer CL,
Wentz K. Non-invasive distension of the small bowel for magnetic-resonance
imaging. Lancet2001; 358:987
-988[CrossRef][Medline]
- Laghi A, Carbone I, Catalano C, et al. Polyethylene glycol solution
as an oral contrast agent for MR imaging of the small bowel.
AJR 2001;177:1333
-1334[Free Full Text]
- Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Ruhm SG, Debatin
JF. Optimization of oral contrast agents for MR imaging of the small bowel.
Radiology2003; 228:279
-283[Abstract/Free Full Text]
- Nakabayashi T, Mochiki E, Kamiyama Y, Haga N, Asao T, Kuwano H.
Erythromycin induces pyloric relaxation accompanied by a contraction of the
gastric body after pylorus-preserving gastrectomy.
Surgery 2003;133:647
-655[CrossRef][Medline]
- Stacher G, Peeters TL, Bergmann H, et al. Erythromycin effects on
gastric emptying, antral motility and plasma motilin and pancreatic
polypeptide concentrations in anorexia nervosa. Gut1993; 34:166
-172[Abstract/Free Full Text]
- Dixon PM, Roulston ME, Nolan DJ. The small bowel enema: a ten year
review. Clin Radiol1993; 47:46
-48[CrossRef][Medline]
- Debatin JF, Patak MA. MRI of the small and large bowel.
Eur Radiol 1999;9:1523
-1534[CrossRef][Medline]
- Patak MA, Weishaupt D, Frohlich JM, Debatin JF. Sequential fast 3D
MRI following oral ingestion of Gd-DOTA: a new means to assess intestinal
transit time. J Magn Reson Imaging1999; 10:474
-476[CrossRef][Medline]
- Maglinte DD, Chernish SM, Kelvin FM, O'Connor KW, Hage JP. Crohn
disease of the small intestine: accuracy and relevance of enteroclysis.
Radiology1992; 184:541
-545[Abstract/Free Full Text]
- Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Prassopoulos P.
MR enteroclysis: technical considerations and clinical applications.
Eur Radiol2002; 12:2651
-2658[Medline]
- Gourtsoyiannis N, Mako E. Imaging of primary small intestinal
tumours by enteroclysis and CT with pathological correlation. Eur
Radiol 1997;7:625
-642[Medline]
- Bender GN, Timmons JH, Williard WC, Carter J. Computed tomographic
enteroclysis: one methodology. Invest Radiol1996; 31:43
-49[Medline]
- Maglinte DD, Lappas JC, Heitkamp DE, Bender GN, Kelvin FM.
Technical refinements in enteroclysis. Radiol Clin North
Am 2003;41:213
-229[CrossRef][Medline]
- Prassopoulos P, Papanikolaou N, Grammatikakis J, Rousomoustakaki M,
Maris T, Gourtsoyiannis N. MR enteroclysis imaging of Crohn disease.
RadioGraphics2001; 21[spec no]:S161
-S172[Abstract/Free Full Text]
- Rieber A, Aschoff A, Nussle K, et al. MRI in the diagnosis of small
bowel disease: use of positive and negative oral contrast media in combination
with enteroclysis. Eur Radiol2000; 10:1377
-1382[CrossRef][Medline]
- Maglinte DD, Lappas JC, Chernish SM, Sellink JL. Intubation routes
for enteroclysis. Radiology1986; 158:553
-554[Abstract/Free Full Text]
- Furukawa A, Saotome T, Yamasaki M, et al. Cross-sectional imaging
in Crohn disease. RadioGraphics2004; 24:689
-702[Abstract/Free Full Text]
- Sood RR, Joubert I, Franklin H, Doyle T, Lomas DJ. Small bowel MRI:
comparison of a polyethylene glycol preparation and water as oral contrast
media. J Magn Reson Imaging2002; 15:401
-408[CrossRef][Medline]
- Laghi A, Borrelli O, Paolantonio P, et al. Contrast enhanced
magnetic resonance imaging of the terminal ileum in children with Crohn's
disease. Gut2003; 52:393
-397[Abstract/Free Full Text]
- Laghi A, Paolantonio P, Catalano C, et al. MR imaging of the small
bowel using polyethylene glycol solution as an oral contrast agent in adults
and children with celiac disease: preliminary observations.
AJR 2003;180:191
-194[Abstract/Free Full Text]
- Schunk K. Small bowel magnetic resonance imaging for inflammatory
bowel disease. Top Magn Reson Imaging2002; 13:409
-425[CrossRef][Medline]
- Wold PB, Fletcher JG, Johnson CD, Sandborn WJ. Assessment of small
bowel Crohn disease: noninvasive peroral CT enterography compared with other
imaging methods and endoscopyfeasibility study.
Radiology2003; 229:275
-281[Abstract/Free Full Text]
- Berne RM. Physiology. St. Louis, MO: Mosby,2004

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. G. Cronin, D. G. Lohan, E. DeLappe, C. Roche, and J. M. Murphy
Duodenal Abnormalities at MR Small-Bowel Follow-Through
Am. J. Roentgenol.,
October 1, 2008;
191(4):
1082 - 1092.
[Abstract]
[Full Text]
[PDF]
|
 |
|